<DOC>
	<DOCNO>NCT00326235</DOCNO>
	<brief_summary>Dependence heroin major public health problem association criminality , law enforcement cost healthcare cost . Managed withdrawal require first step long term drug-free treatment heroin addict . Methadone clonidine mainstay treatment relief heroin withdrawal symptom limitation . The purpose study evaluate efficacy buspirone alleviation withdrawal symptom experience heroin addict stop use heroin . Buspirone non opiate drug abuse potential , sedate effect withdrawal symptom .</brief_summary>
	<brief_title>Effects Buspirone Opiate Withdrawal</brief_title>
	<detailed_description>In attempt develop new opiate detoxification approach , author assess efficacy buspirone treatment acute heroin withdrawal . Buspirone , drug interact serotonergic system select evidence decrease serotonergic neurotransmission may involve opiate withdrawal symptomatology . Hospitalized heroin addict randomize 4 group : 1 ) placebo ; 2 ) methadone ; 3 ) buspirone 30 mg daily ; 4 ) buspirone 45 mg daily . The double-blind trial start patient 5-day methadone stabilization period end 30 mg dose . This follow day 6 12 placebo group 1 methadone taper group 2 . Because delayed action , buspirone start day 1 group 3 4 continue , methadone discontinuation , day 12 . On day 13 , drug placebo discontinue patient observe day 14 . Withdrawal symptom assess `` Subjective Opiate Withdrawal Scale '' ( SOWS ) `` Objective Opiate Withdrawal Scale '' ( OOWS ) . Participants meet research assistant daily 30 minute inpatient unit . The study interfere schedule ward activity . Results far indicate SOWS OOWS score significantly high Placebo group Methadone , Buspirone 30 mg Buspirone 45 mg group . There significant difference SOWS OOWS score Methadone group compare two Buspirone group two Buspirone group compare one another . Thus buspirone , non opiate drug abuse potential , safe side effect profile withdrawal symptom dose 30 45 mg , effective methadone taper alleviate withdrawal symptom heroin addict stabilize 5 day , withdrawn , methadone . Additional analysis perform use data collect course study .</detailed_description>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>fulfil DSM IV diagnostic criterion opioid dependence use heroin daily least prior 6 month claim heroin use least 2.5g/week physical dependence opiate determine history observation admission urine sample demonstrate heroin use express willingness participate randomize , doubleblind , placebocontrolled study 14 day . current past Axis I psychiatric disorder opioid dependence evidence significant neurological , gastrointestinal , hepatic , cardiovascular , renal , endocrine hematologic disease seropositive status human immunodeficiency virus</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2005</verification_date>
	<keyword>Opioid withdrawal</keyword>
	<keyword>Buspirone</keyword>
	<keyword>Methadone taper</keyword>
</DOC>